Healthcare-Associated Infections

HAIs Overview - Hospital's Hidden Foes

• Definition: Infections acquired in a healthcare setting, typically after ≥48 hours of admission, not present or incubating at admission.
• Common Types:
  • Catheter-Associated Urinary Tract Infection (CAUTI)
  • Central Line-Associated Bloodstream Infection (CLABSI)
  • Ventilator-Associated Pneumonia (VAP)
  • Surgical Site Infection (SSI)
  • Clostridioides difficile Infection (CDI)
• Epidemiology (India): Significant burden; incidence varies (e.g., VAP 10-30% in ICUs).
• Overall Burden: ↑ morbidity, mortality, length of stay, healthcare costs.

⭐ CAUTI is the most common type of HAI globally and in India.

CAUTI & CLABSI - Invasive Line Invaders

• Pathogenesis: Biofilm formation on catheter (CAUTI); Migration of skin organisms, hub contamination (CLABSI).
• Common Organisms:
  • CAUTI: E. coli, Klebsiella, Proteus, Enterococcus, Candida.
  • CLABSI: Coagulase-negative staphylococci (CoNS), S. aureus, Gram-negative rods, Candida.
• Risk Factors: Prolonged catheterization (CAUTI >48h; CLABSI >2 calendar days), improper insertion/care, female (CAUTI), femoral/jugular sites (CLABSI).
• Diagnosis (CDC Criteria):
  • CAUTI: Symptoms (fever, dysuria) + urine culture ≥$10^5$ CFU/mL (≤2 species) OR pyuria + ≥$10^3$ CFU/mL if catheter removed within 48h.
  • CLABSI: Recognized pathogen from ≥1 blood culture OR common commensal from ≥2 blood cultures (separate occasions) + symptoms (fever, chills), with CVC in place ≥2 days.
• Key Prevention: Hand hygiene, aseptic insertion, daily review of necessity, prompt removal when no longer indicated.

⭐ The single most effective measure to prevent CAUTI is limiting catheter use and ensuring prompt removal when no longer indicated.

Prevention Bundles Comparison: CAUTI vs. CLABSI

VAP & SSI - Surgical & Airy Afflictions

• Ventilator-Associated Pneumonia (VAP)
  • Pathogenesis: Microaspiration of oropharyngeal/gastric flora. Occurs >48h post-intubation.
  • Organisms: Pseudomonas aeruginosa, Acinetobacter spp., Staphylococcus aureus (MRSA).
  • Diagnosis: New/progressive pulmonary infiltrate + ≥2 clinical signs (fever >38°C, leukocytosis/leukopenia, purulent secretions). Clinical Pulmonary Infection Score (CPIS) > 6 highly suggestive.
  • Prevention: Head-of-bed elevation 30-45°, oral care (chlorhexidine), daily sedation interruption & assessment of readiness to extubate. 📌 I COUGH.
• Surgical Site Infection (SSI)
  • Pathogenesis: Contamination during surgery. Risk factors: obesity, diabetes, smoking, immunosuppression.
  • Organisms: Staphylococcus aureus (most common), Coagulase-negative staphylococci, Enterococci, E. coli, Pseudomonas aeruginosa.
  • Prevention: Pre-operative antibiotics (e.g., Cefazolin 30-60 min before incision; Vancomycin/Fluoroquinolones 60-120 min), appropriate hair removal, skin antisepsis, glycemic control (glucose <200 mg/dL).
  • Classification:

    Type	Location
    Superficial Incisional	Involves only skin & subcutaneous tissue
    Deep Incisional	Involves deep soft tissues (e.g., fascia, muscle)
    Organ/Space	Involves any organ/space opened during surgery

⭐ Staphylococcus aureus is the most common cause of SSIs, while Pseudomonas aeruginosa is a key pathogen in late-onset VAP (>5 days).

C. diff & MDR - Gut Wreckers & Drug Dodgers

• C. difficile Infection (CDI):
  • Patho: Toxins A & B damage gut. Risk: Antibiotics (clindamycin, cephalosporins).
  • Dx: Stool NAAT or GDH + Toxin assay.
  • Tx (Initial, non-severe): Oral Vancomycin 125mg QID or Fidaxomicin 200mg BID for 10 days.
  • High recurrence.
• Multidrug-Resistant Organisms (MDROs):
  • Key types: MRSA, VRE, ESBLs, CRE.
  • Implications: ↑morbidity, ↑hospital stays.
  • Control: Hand hygiene, contact precautions, stewardship.

⭐ First-line for initial, non-severe CDI: Oral Vancomycin 125mg QID or Fidaxomicin 200mg BID for 10 days.

HAI Prevention - Germ Warfare Guide

• Standard Precautions: Universal: hand hygiene, PPE (gloves, gowns, masks), safe injections, cough etiquette.
• Hand Hygiene: 📌 WHO 5 Moments (see diagram). ABHR preferred; soap & water if soiled.

  ⭐ Hand hygiene is the single most important measure to prevent HAIs.

• Transmission-Based Precautions: For known/suspected pathogens.

• Key Strategies:
  • Environmental Cleaning: Regular disinfection, high-touch surfaces.
  • Antimicrobial Stewardship: Optimize use, dose, duration.
  • HAI Surveillance: Monitor rates, detect outbreaks, feedback.
  • BMW Management: Safe segregation, treatment, disposal of biomedical waste.

High‑Yield Points - ⚡ Biggest Takeaways

• CLABSI: Implement prevention bundles. Key pathogens: S. aureus, Gram-negatives.
• CAUTI: Most common HAI. E. coli frequent. Prompt catheter removal is vital.
• VAP: Prevent with head elevation, oral chlorhexidine. Pathogens: Pseudomonas, MRSA.
• SSI: Prophylactic antibiotics <60 mins pre-incision. S. aureus is a major cause.
• C. difficile: Causes antibiotic-associated diarrhea. Treat with oral vancomycin/fidaxomicin.
• Hand hygiene: Single most effective measure to prevent HAIs.
• MDROs (MRSA, CRE): Require contact precautions and active surveillance.